Natera is a genetic testing and diagnostics company that specializes in developing and commercializing DNA testing services for various medical applications. Natera’s proprietary technology platform, called the Constellation system, enables the analysis of complex biological information, providing insights into various genetic disorders and diseases.
Natera’s primary focus is on reproductive health, cancer, and organ transplantation. In reproductive health, the company offers a range of genetic testing services, including non-invasive prenatal testing, preimplantation genetic testing, and carrier screening. Natera’s cancer tests use circulating tumor DNA to identify cancer at an early stage and monitor disease progression.
The company was founded in 2003 and is headquartered in San Carlos, California. It has grown rapidly over the years and now has more than 1,000 employees. Natera is committed to advancing the field of genetic testing and diagnostics and providing high-quality, affordable testing services to patients and healthcare providers.